Januvia

LONDON -- U.S. stock futures were flat to weaker Wednesday ahead of a report on employment and the Fed's assessment of the economy, as calm was restored to markets after the Dubai debt j...Thomson Reuters' global pharma forecast for next year.Alexandra Kibble of Thomson Reuters identifies the products and therapy areas to watch next year.WALTHAM, Mass., Dec.Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the type 2 diabetes drug market in Brazil will grow from $417 million in 2008 to $834 million in 2013.Ipsen , an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 analogue originating from Ipsen's research and developed by Roche...With a slew of economic data slated for release later today, traders have placed any enthusiasm regarding yesterday's roughly 1.2% market surge on the back burner...